Moksh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.37 Cr
- Paid Up Capital ₹ 1.30 Cr
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 10.00 Cr
- Revenue Growth %
- Profit Growth -429.74%
- Ebitda 653.65%
- Net Worth -556.42%
- Total Assets 25.11%
About Moksh Pharmaceuticals
Moksh Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 June 2017 (Seven years and seven months 29 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.37 Cr and a paid-up capital of Rs 1.30 Cr.
The company has closed loans amounting to ₹10.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pradipkumar Vyas, Vipulbhai Patel, and Pinalkumar Patel serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304GJ2017PTC097841
-
Company No.
097841
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jun 2017
-
Date of AGM
10 Nov 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Moksh Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradipkumar Vyas
|
Director | 12-Jun-2017 | Current |
|
Vipulbhai Patel
|
Director | 12-Jun-2017 | Current |
|
Pinalkumar Patel
|
Director | 12-Jun-2017 | Current |
Financial Performance of Moksh Pharmaceuticals.
Moksh Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 429.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 556.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Moksh Pharmaceuticals?
In 2020, Moksh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Yogi Suryam LlpVipulbhai Patel is a mutual person
-
Wellcross Pharmaceuticals Private Limited
Pinalkumar Patel is a mutual person
Charges (Loans)
₹0
₹10.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2018 | State Bank Of India | ₹5.00 Cr | Satisfied |
| 01 Nov 2018 | State Bank Of India | ₹5.00 Cr | Satisfied |
How Many Employees Work at Moksh Pharmaceuticals?
Unlock and access historical data on people associated with Moksh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Moksh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moksh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.